What is Evolent Health's stock symbol?
Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."
Where is Evolent Health's stock going? Where will Evolent Health's stock price be in 2017?
8 brokers have issued 12-month price objectives for Evolent Health's shares. Their predictions range from $24.00 to $31.00. On average, they anticipate Evolent Health's stock price to reach $27.50 in the next twelve months.
When will Evolent Health announce their earnings?
Evolent Health is scheduled to release their next quarterly earnings announcement on Thursday, February, 23rd 2017.
What are analysts saying about Evolent Health stock?
Here are some recent quotes from research analysts about Evolent Health stock:
According to Zacks Investment Research, "Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. " (2/1/2017)
Leerink Swann analysts commented, "We continue to be impressed with the firm’s rapid growth rate and ability to deploy the identifi platform to a wide array of customers." (5/16/2016)
Who owns Evolent Health stock?
Evolent Health's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (3.30%), Alyeska Investment Group L.P. (0.96%), Columbia Wanger Asset Management LLC (0.68%), Loomis Sayles & Co. L P (0.59%), Perceptive Advisors LLC (0.45%) and Two Sigma Investments LP (0.44%). Company insiders that own Evolent Health stock include Board Co Advisory, Chad Pomeroy, Frank J Williams, Gary Piefer, Jonathan Weinberg, Michael D'amato, Nicholas Mcgrane, Seth Blackley and Thomas Peterson III.
Who sold Evolent Health stock? Who is selling Evolent Health stock?
Evolent Health's stock was sold by a variety of institutional investors in the last quarter, including Friess Associates LLC, FMR LLC, Loomis Sayles & Co. L P, Renaissance Technologies LLC and Wall Street Associates. Company insiders that have sold Evolent Health stock in the last year include Board Co Advisory, Chad Pomeroy, Frank J Williams, Jonathan Weinberg, Nicholas Mcgrane, Seth Blackley and Thomas Peterson III.
Who bought Evolent Health stock? Who is buying Evolent Health stock?
Evolent Health's stock was acquired by a variety of institutional investors in the last quarter, including Columbia Wanger Asset Management LLC, Perceptive Advisors LLC, Alyeska Investment Group L.P., Two Sigma Investments LP, Nicholas Investment Partners LP, Russell Investments Group Ltd., Redmond Asset Management LLC and Trexquant Investment LP. Company insiders that have bought Evolent Health stock in the last two years include Gary Piefer and Michael D'amato.
How do I buy Evolent Health stock?
Shares of Evolent Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Evolent Health stock cost?
One share of Evolent Health stock can currently be purchased for approximately $19.60.